OrbiMed Advisors »

Ceribell shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Ceribell (CBLL) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Ceribell

Tip: Access up to 7 years of quarterly data

All positions including Ceribell held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ceribell by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.2M 113k 19.21
2024-12-31 $2.9M 113k 25.88

More positions owned by OrbiMed Advisors

Boston Scientific Corporation (BSX)
Edgewise Therapeutics (EWTX)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Enliven Therapeutics (ELVN)
Alnylam Pharmaceuticals (ALNY)
Stryker Corporation (SYK)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)
Argenx Se Sponsored Adr (ARGX)
Sionna Therapeutics (SION)
Upstream Bio (UPB)
Disc Medicine (IRON)
Caris Life Sciences (CAI)
Silverback Therapeutics (SPRY)

View all positions for OrbiMed Advisors

Top funds holding Ceribell

FMR
Tpg Gp A
Red Tree Management
BlackRock
Vanguard Group
Yu Fan
ABG-WTT Global Life Science Capital Partners GP
TimesSquare Capital Management
Federated Investors
Millennium Management
Geode Capital Management
Massachusetts Financial Services
Franklin Resources
CenterBook Partners
Redmile Group

View all funds holding Ceribell